|
AU2008207646A1
|
|
Methods and compositions for modulating interleukin-21 receptor activity
|
|
AU2008203282A1
|
|
Human CTLA-8 and uses of CTLA-8-related proteins
|
|
AU2007211873A1
|
|
Novel aggrecanase molecules
|
|
AU2007203133A1
|
|
Inhibition of Thrombosis by Treatment with P-Selectin Antagonists
|
|
AU2006201843A1
|
|
TRADE Molecules and Uses Related Thereto
|
|
AU2006200028A1
|
|
Methods for selectively stimulating proliferation of T cells (D3)
|
|
US2006099177A1
|
|
Methods for selectively enriching TH1 and TH2 cells
|
|
AU2005227386A1
|
|
Neuronal uses of BMP-11
|
|
AU2005202229A1
|
|
Cytokine Receptor Chain
|
|
US2005165221A1
|
|
Methods for producing Factor VIII proteins
|
|
AU2004231176A1
|
|
Human CTLA-8 and uses of CTLA-8-related proteins
|
|
US2005277126A1
|
|
Method and compositions for treating asthma
|
|
US2005002898A1
|
|
N-TRADD active site and uses thereof
|
|
US2005042220A1
|
|
Monoclonal antibodies against interleukin-22
|
|
BRPI0411784A
|
|
antibodies to and use of interleukin-22
|
|
AU2003262307A1
|
|
Human GIL-19/AE289 proteins and polynucleotides encoding same
|
|
AU2003257877A1
|
|
Methods for selectively stimulating proliferation of T cells (D2)
|
|
AU2003244613A1
|
|
Neuronal uses of BMP-11
|
|
AU2003231607A8
|
|
Treatment of Kaposi's sarcoma with IL-12
|
|
AU2003231603A1
|
|
Use of follistatin to modulate GDF-8 and BMP-11
|
